查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1647935

气喘监测设备市场 - 全球产业规模、份额、趋势、机会和预测，按设备、按最终用户、按地区和竞争细分，2020-2030 年

Asthma Monitoring Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By End-User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球气喘监测设备市场价值为 2.8513 亿美元，预计到 2030 年将达到 4.0586 亿美元，预测期内复合年增长率为 6.26%。全球气喘监测设备市场正在经历持续成长，这得益于气喘盛行率的上升、气喘管理意识的增强以及医疗技术的不断进步。气喘是一种以呼吸道发炎和狭窄为特征的慢性呼吸系统疾病，影响着全球数百万人。监测设备在评估肺功能、追踪症状和管理治疗以减少发作和提高生活品质方面发挥着至关重要的作用。根据世界卫生组织 (WHO) 的数据，全球有近 5 亿人患有气喘和慢性阻塞性肺病 (COPD)，这两种疾病每年导致近 400 万人死亡，其中超过 100 万人死于70岁以下的个人。令人震惊的是，90% 的过早死亡发生在中低收入国家 (LMIC)。政府和医疗保健组织正在积极推动更好的气喘管理，从而促进监测设备的普及。对早期检测和预防的公众教育进一步鼓励了人们持续使用这些设备。然而，先进的气喘监测设备成本高昂，可能会让一些患者难以承受，特别是在低收入地区，这限制了其广泛应用。此外，虽然城市人口越来越多地使用这些设备，但农村地区仍然面临认知度和可近性方面的挑战，阻碍了市场渗透。

市场概况
预测期 2026-2030
2024 年市场规模 2.8513亿美元
2030 年市场规模 4.0586亿美元
2025-2030 年复合年增长率 6.26%
成长最快的领域 智慧吸入器
最大的市场 北美洲

2024 年 10 月，FDA 和疾病管制与预防中心 (CDC) 在《发病率和死亡率週报》中发布了 2024 年全国青少年烟草调查 (NYTS) 有关青少年烟草使用的调查结果。资料显示，225万名国中和高中学生报告称，在过去30天里，他们有一天或多天使用过至少一种烟草产品。发展中国家医疗保健基础设施的扩展和人们对气喘管理的认识的不断提高为市场提供了巨大的成长机会。新兴市场城市化进程的加速可能会推动对气喘监测解决方案的需求。此外，监测设备与远距医疗平台的整合使医疗保健提供者能够远端追踪和调整患者的治疗，尤其是在偏远地区。预计未来几年这一趋势将会成长。儘管高成本和区域接入差异等挑战依然存在，但新兴市场的机会以及远距医疗的整合为市场持续成长提供了途径。透过专注于创新和提高患者参与度，气喘监测设备市场可望快速发展，为全球气喘患者提供更有效的解决方案。

主要市场驱动因素

哮喘盛行率上升

远端患者监控日益受到重视

提高认识和教育

主要市场挑战

有限报销政策

互通性问题

主要市场趋势

远距医疗和远端监控

关注儿童气喘监测

分段洞察

设备洞察

最终使用者见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球气喘监测设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按设备（肺量计、智慧吸入器、峰值流量计）
    • 按最终使用者（医院和诊所、家庭护理、诊断实验室）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司分类（2024）
  • 市场地图
  • 按设备
  • 按最终用户
  • 按地区

第 6 章：北美气喘监测设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按设备
    • 按最终用户
    • 按国家
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲气喘监测设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按设备
    • 按最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区气喘监测设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按设备
    • 按最终用户
    • 按国家
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲气喘监测设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按设备
    • 按最终用户
    • 按国家
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲气喘监测设备市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按设备
    • 按最终用户
    • 按国家
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章：全球气喘监测设备市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips NV
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc.

第 16 章：策略建议

第17章 调査会社について・免责事项

简介目录
Product Code: 20032

Global Asthma Monitoring Device Market was valued at USD 285.13 Million in 2024 and is expected to reach USD 405.86 Million by 2030 with a CAGR of 6.26% during the forecast period. The global asthma monitoring device market is experiencing consistent growth driven by the increasing prevalence of asthma, heightened awareness of asthma management, and continuous advancements in medical technologies. Asthma, a chronic respiratory condition marked by airway inflammation and narrowing, affects millions of individuals globally. Monitoring devices play a vital role in evaluating lung function, tracking symptoms, and managing treatment to reduce flare-ups and enhance quality of life. According to the World Health Organization (WHO), nearly half a billion people live with asthma and chronic obstructive pulmonary disease (COPD), and these two conditions are responsible for almost 4 million deaths annually, with over 1 million of those deaths occurring prematurely in individuals under 70 years old. Alarmingly, 90% of premature deaths occur in low- and middle-income countries (LMICs). Governments and healthcare organizations are actively promoting better asthma management, leading to greater adoption of monitoring devices. Public education on early detection and prevention further encourages consistent use of these devices. However, the high cost of advanced asthma monitoring equipment may be prohibitive for some patients, particularly in lower-income regions, limiting their widespread adoption. Additionally, while urban populations increasingly use these devices, rural areas continue to face challenges with awareness and accessibility, impeding market penetration.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 285.13 Million
Market Size 2030USD 405.86 Million
CAGR 2025-20306.26%
Fastest Growing SegmentSmart Inhalers
Largest MarketNorth America

In October 2024, the FDA and the Centers for Disease Control and Prevention (CDC) published findings from the 2024 National Youth Tobacco Survey (NYTS) regarding youth tobacco use in the Morbidity and Mortality Weekly Report. The data revealed that 2.25 million middle and high school students reported using at least one tobacco product on one or more days in the past 30 days. The expansion of healthcare infrastructure and growing awareness about asthma management in developing countries offer significant growth opportunities for the market. The rising urbanization in emerging markets is likely to drive the demand for asthma monitoring solutions. Moreover, the integration of monitoring devices with telemedicine platforms enables healthcare providers to remotely track and adjust treatments for patients, especially in remote areas. This trend is expected to grow in the coming years. Although challenges such as high costs and regional access disparities remain, opportunities in emerging markets, along with the integration of telemedicine, offer avenues for continued market growth. With a focus on innovation and improved patient engagement, the asthma monitoring device market is poised to evolve rapidly, providing more effective solutions for asthma patients around the world.

Key Market Drivers

Rising Prevalence of Asthma

The growing global prevalence of asthma is expected to significantly drive the expansion of the Global Asthma Monitoring Device Market. According to the GINA 2024 Report, asthma is one of the most common chronic non-communicable diseases, affecting over 300 million people and causing around 1,000 deaths daily worldwide, many of which are preventable. As asthma incidence continues to rise, the demand for effective and efficient monitoring solutions to manage and control the condition is also increasing. This heightened demand is expected to spur innovation and attract investment in asthma monitoring devices, further fueling market growth. Asthma monitoring devices play a crucial role in enabling individuals to track and manage their respiratory health, providing real-time data and insights to both patients and healthcare professionals. As patient awareness of the importance of proactive asthma management grows, the adoption of these monitoring devices is expected to increase, supporting market growth. Additionally, advancements in technology such as the integration of smart features and wireless connectivity are improving user experience and enabling remote monitoring, which will further drive the market's expansion. In Ireland, for example, the Asthma Society of Ireland reports that 890,000 people will experience asthma at some point in their lives, with 380,000 individuals currently affected. One in 13 people and one in 10 children in Ireland are living with asthma. The rising asthma prevalence, combined with the growing emphasis on personalized healthcare and the adoption of innovative technologies, positions the asthma monitoring device market for substantial growth in the near future.

Growing Emphasis on Remote Patient Monitoring

The burgeoning emphasis on Remote Patient Monitoring (RPM) is poised to be a key catalyst in propelling the growth of the Global Asthma Monitoring Device Market. With a paradigm shift towards decentralized healthcare, the demand for Asthma Monitoring Devices is escalating due to their integral role in facilitating remote tracking of patients' respiratory health. As healthcare systems increasingly prioritize preventive care and patient-centric approaches, these monitoring devices offer a crucial solution for continuous, real-time assessment without the necessity of frequent in-person visits. The integration of Asthma Monitoring Devices with wireless connectivity and smart technologies enables seamless data transmission to healthcare professionals, fostering timely intervention and personalized care plans. This not only empowers patients to actively manage their condition but also allows healthcare providers to make informed decisions remotely, improving overall patient outcomes. The growing adoption of telehealth practices and the need for efficient chronic disease management, especially in the context of asthma, positions the Asthma Monitoring Device Market at the forefront of technological innovation and remote healthcare delivery. This trend is anticipated to drive sustained market growth as the healthcare landscape continues to evolve towards patient-centric, technology-enabled solutions.

Increasing Awareness and Education

The growth of the Global Asthma Monitoring Device Market is set to be significantly driven by a rise in awareness and education around respiratory health. As awareness campaigns and educational efforts gain momentum, more individuals are recognizing the importance of effectively monitoring and managing asthma. For example, Philips' awareness campaign educates consumers on asthma and helps people better manage their symptoms. This growing awareness is leading to a heightened demand for asthma monitoring devices, as people adopt a more proactive and informed approach to respiratory care.

Education on the benefits of continuous asthma monitoring, as well as the role these devices play in early detection and management, is key to encouraging their widespread adoption. Patients are increasingly seeking these devices as part of their regular healthcare routines. Additionally, CIPLA, India's third-largest pharmaceutical company, has launched a campaign (#InhalersHainSahi) to raise awareness about asthma and emphasize the vital role inhalers play in managing the condition. As asthma continues to be a global health challenge, improving awareness and preparedness is critical to effectively combating the disease.

Investing in asthma prevention efforts, including health education and innovative strategies, is essential to raising community awareness and promoting preventative practices. These educational initiatives are also beneficial for healthcare professionals, who are now better equipped to recommend and incorporate asthma monitoring devices into personalized care plans, further driving market growth. The convergence of technology and healthcare education is particularly impactful, as informed consumers are more inclined to embrace innovative solutions. As a result, the Global Asthma Monitoring Device Market is poised to benefit significantly from this increasing awareness, expanding its market base as more individuals take a proactive approach to managing their respiratory health.

Key Market Challenges

Limited Reimbursement Policies

Limited reimbursement policies pose a significant obstacle to the growth of the Global Asthma Monitoring Device Market. The financial landscape of healthcare is a crucial determinant of consumer adoption and healthcare provider recommendation of monitoring devices. When reimbursement policies are restrictive or inadequately cover the costs associated with Asthma Monitoring Devices, both patients and healthcare institutions may be deterred from investing in these technologies. Healthcare providers often rely on reimbursement support to justify the integration of new technologies into patient care. Limited coverage for asthma monitoring devices may result in decreased willingness to prescribe or recommend these devices, hindering their market penetration. This, in turn, affects patient access and adoption rates, especially among those who depend on insurance coverage for medical expenses. For patients, out-of-pocket costs can be a significant barrier to acquiring these devices, leading to suboptimal management of asthma. The market's growth is inherently linked to the alignment of reimbursement policies with the value proposition of asthma monitoring devices, and addressing these limitations is pivotal for fostering widespread adoption and ensuring the sustained growth of the Asthma Monitoring Device Market on a global scale.

Interoperability Issues

Interoperability issues present a formidable barrier to the growth of the Global Asthma Monitoring Device Market. The seamless exchange of data between various healthcare systems, electronic health records (EHRs), and monitoring devices is crucial for the effective management of chronic conditions like asthma. However, disparate standards and a lack of standardized protocols for data communication hinder the smooth integration of asthma monitoring devices into existing healthcare ecosystems. When interoperability is compromised, healthcare providers face challenges in accessing and utilizing the data generated by these devices, leading to fragmented patient care. The inability of asthma monitoring devices to seamlessly communicate with other health information systems not only impedes efficient care coordination but also diminishes the overall value proposition of these devices. Moreover, interoperability issues may contribute to increased implementation costs for healthcare institutions, as they may need to invest in additional infrastructure or customized solutions to overcome compatibility challenges. This, in turn, can slow down the adoption rate of asthma monitoring devices on a broader scale. To foster the growth of the Asthma Monitoring Device Market, addressing interoperability challenges is imperative. Standardizing communication protocols and promoting interoperable solutions will enhance the utility of these devices, driving their integration into comprehensive healthcare strategies and ultimately benefiting both healthcare providers and patients.

Key Market Trends

Telehealth and Remote Monitoring

The Global Asthma Monitoring Device Market is set to experience accelerated growth due to the rising prominence of telehealth and remote monitoring solutions. According to data from the US Centers for Disease Control (CDC), published in the American Journal of Managed Care, asthma is estimated to cost USD 80 billion annually. Telehealth, combined with asthma monitoring devices, presents a transformative approach to managing respiratory health. The convenience and accessibility of remote monitoring empower patients to actively engage in their care, facilitating early interventions and tailored treatment plans.

By integrating asthma monitoring devices with telehealth platforms, real-time data can be transmitted to healthcare providers, enabling proactive decision-making without the need for in-person visits. This not only boosts patient engagement but also streamlines healthcare delivery, particularly in remote or underserved areas. The global shift toward telehealth, fueled by technological advancements and the growing demand for virtual healthcare options, creates a favorable environment for the widespread adoption of asthma monitoring devices.

For example, in February 2024, Singapore-based respiratory monitoring device company Aevice Health partnered with London-based Jiva.ai to develop a remote patient monitoring platform that enables individuals with asthma to track their condition and predict asthma attacks. This collaboration, partly funded by the UK government's Innovate UK business grant scheme and Singapore's Enterprise Singapore, leverages the FDA-approved AeviceMD, a wearable smart stethoscope that continuously monitors asthma biomarkers. This system allows patients to monitor their condition from home while providing healthcare providers with valuable insights to optimize care. As telehealth becomes a core element of modern healthcare systems, the integration of telehealth with asthma monitoring devices is poised to drive market growth by delivering efficient, patient-centered solutions that align with the evolving healthcare landscape.

Focus on Pediatric Asthma Monitoring

The Global Asthma Monitoring Device Market is poised for substantial growth with an increasing focus on pediatric asthma monitoring. Recognizing the unique needs and challenges of managing asthma in children, there is a growing demand for specialized monitoring devices tailored to the pediatric population. This emphasis on pediatric asthma care is driven by a heightened awareness of the prevalence of childhood asthma and the importance of early intervention. Pediatric asthma monitoring devices offer features specifically designed to address the developmental and behavioral aspects of children, making it easier for parents and healthcare providers to manage the condition effectively. The integration of child-friendly designs, user-friendly interfaces, and interactive features enhances compliance and engagement, ensuring accurate and consistent monitoring. Moreover, the rising incidence of pediatric asthma, coupled with a proactive approach towards preventive healthcare, positions the market for pediatric asthma monitoring devices as a critical component in the overall asthma management landscape. As healthcare providers and parents prioritize the well-being of children with asthma, the market is expected to witness sustained growth by catering to the specific needs of this demographic, ultimately contributing to improved health outcomes for pediatric asthma patients globally.

Segmental Insights

Device Insights

Based on Device, the Smart Inhalers emerged as the fastest growing segment in the global market for Asthma Monitoring Device during the forecast period. The Global Asthma Monitoring Device Market is set to experience robust growth driven by the integration of Smart Inhalers. These innovative devices represent a paradigm shift in asthma management, combining traditional inhalers with digital technology to provide real-time data and insights. Smart Inhalers not only ensure accurate medication delivery but also offer features such as dose reminders, inhalation technique feedback, and wireless connectivity. The smart features of these inhalers empower patients to actively engage in their asthma management by tracking medication usage and monitoring respiratory patterns. This data is then seamlessly transmitted to healthcare providers, enabling personalized treatment plans and timely interventions. The enhanced connectivity of Smart Inhalers aligns with the broader trends in digital health and telemedicine, facilitating remote patient monitoring and improving overall healthcare outcomes. As the demand for more efficient and patient-centric healthcare solutions grows, the market for Smart Inhalers is expected to expand significantly. The convergence of respiratory care with smart technology not only addresses the evolving needs of asthma patients but also positions the Global Asthma Monitoring Device Market at the forefront of innovation in chronic disease management.

End-User Insights

Based on End-User, the Hospitals & Clinics emerged as the dominating segment in the global market for Asthma Monitoring Device in 2024. Hospitals and clinics are poised to be key drivers of growth in the Global Asthma Monitoring Device Market. As healthcare institutions increasingly prioritize comprehensive and patient-centric care, the integration of asthma monitoring devices becomes imperative for optimizing respiratory health management. Hospitals and clinics, acting as pivotal points in the healthcare delivery system, are instrumental in shaping the adoption and utilization of these devices. The demand for asthma monitoring devices is expected to surge in healthcare settings, driven by the need for more efficient and proactive approaches to respiratory care. These devices offer healthcare providers valuable real-time data, facilitating informed decision-making and personalized treatment plans. The integration of asthma monitoring devices aligns with the broader trend of digital transformation in healthcare, enhancing the quality of patient care and streamlining clinical workflows. Moreover, the rising prevalence of asthma and the emphasis on preventive healthcare further underscore the significance of monitoring devices in hospitals and clinics. As these institutions prioritize the implementation of advanced technologies to improve patient outcomes, the Global Asthma Monitoring Device Market stands to benefit significantly from increased adoption within the healthcare sector.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Asthma Monitoring Device Market in 2024. The North America region is poised to be a major catalyst for driving the growth of the Global Asthma Monitoring Device Market. Several factors contribute to this, including a robust healthcare infrastructure, a high prevalence of asthma cases, and a strong emphasis on technological innovation in healthcare. In North America, particularly in the United States and Canada, there is a heightened awareness of respiratory health, and a growing number of individuals are seeking advanced solutions for asthma management. The region's well-established healthcare ecosystem, characterized by a network of hospitals, clinics, and research institutions, facilitates the integration and adoption of asthma monitoring devices. Furthermore, the region's affinity for cutting-edge healthcare technologies, coupled with a favorable regulatory environment, encourages the development and deployment of innovative asthma monitoring solutions. The presence of key market players and research and development activities in North America further propels market growth. As healthcare stakeholders increasingly prioritize preventive care and patient engagement, the demand for asthma monitoring devices is expected to escalate in North America. The region's influential role in shaping healthcare trends positions it as a driving force behind the expansion of the Global Asthma Monitoring Device Market.

Key Market Players

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc.

Report Scope:

In this report, the Global Asthma Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Monitoring Device Market, By Product:

  • Spirometer
  • Smart Inhalers
  • Peak Flow Meter

Asthma Monitoring Device Market, By End-User:

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Laboratories

Asthma Monitoring Device Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Monitoring Device Market.

Available Customizations:

Global Asthma Monitoring Device market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Monitoring Device Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 5.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Device
  • 5.3.2 By End-User
  • 5.3.3 By Region

6. North America Asthma Monitoring Device Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 6.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Asthma Monitoring Device Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Asthma Monitoring Device Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Asthma Monitoring Device Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device
        • 6.3.3.2.2. By End-User

7. Europe Asthma Monitoring Device Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 7.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Asthma Monitoring Device Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device
        • 7.3.1.2.2. By End-User
    • 7.3.2. Germany Asthma Monitoring Device Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Asthma Monitoring Device Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Asthma Monitoring Device Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Asthma Monitoring Device Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device
        • 7.3.5.2.2. By End-User

8. Asia Pacific Asthma Monitoring Device Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 8.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Asthma Monitoring Device Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Asthma Monitoring Device Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Asthma Monitoring Device Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Asthma Monitoring Device Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Asthma Monitoring Device Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device
        • 8.3.5.2.2. By End-User

9. South America Asthma Monitoring Device Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 9.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Asthma Monitoring Device Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device
        • 9.3.1.2.2. By End-User
    • 9.3.2. Argentina Asthma Monitoring Device Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device
        • 9.3.2.2.2. By End-User
    • 9.3.3. Colombia Asthma Monitoring Device Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device
        • 9.3.3.2.2. By End-User

10. Middle East and Africa Asthma Monitoring Device Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 10.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Asthma Monitoring Device Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device
        • 10.3.1.2.2. By End-User
    • 10.3.2. Saudi Arabia Asthma Monitoring Device Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device
        • 10.3.2.2.2. By End-User
    • 10.3.3. UAE Asthma Monitoring Device Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Asthma Monitoring Device Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COSMED srl.
    • 15.1.1. Business Overview
    • 15.1.2. Product Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. Teleflex Incorporated.
  • 15.3. SCHILLER.
  • 15.4. Hill-Rom, Inc.
  • 15.5. Koninklijke Philips N.V.
  • 15.6. ICU Medical, Inc.
  • 15.7. SDI Diagnostics
  • 15.8. AstraZeneca plc.
  • 15.9. Merck & Co., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer